Topic

Cerezyme (imiglucerase)

A collection of 15 issues

How to Get Cerezyme (Imiglucerase) Covered by UnitedHealthcare in Georgia: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Cerezyme Covered by UnitedHealthcare in Georgia UnitedHealthcare requires prior authorization for Cerezyme (imiglucerase) for Gaucher disease. Key steps: 1) Confirm Type 1 Gaucher diagnosis with enzyme testing, 2) Submit PA through UnitedHealthcare Provider Portal with specialist documentation, 3) If denied, file internal appeal within 180 days, then
6 min read

How to Get Cerezyme (Imiglucerase) Covered by Cigna in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Cerezyme (Imiglucerase) Covered by Cigna in North Carolina Yes, Cigna covers Cerezyme (imiglucerase) for Type 1 Gaucher disease with prior authorization. Your fastest path to approval requires: (1) confirmed Gaucher disease Type 1 diagnosis with enzyme testing and genetic confirmation, (2) specialist prescriber (hematologist/geneticist), and (3)
5 min read

How to Get Cerezyme (Imiglucerase) Approved by UnitedHealthcare in New Jersey: Complete Appeals Guide

Answer Box: Getting Cerezyme Covered by UnitedHealthcare in New Jersey Cerezyme (imiglucerase) requires prior authorization from UnitedHealthcare/OptumRx in New Jersey and may face step therapy requirements. To get coverage: 1. Submit PA request via UnitedHealthcare Provider Portal with Gaucher disease confirmation and specialist documentation 2. Request step therapy exception
6 min read

If Cerezyme (Imiglucerase) Isn't Approved by Blue Cross Blue Shield in Virginia: Formulary Alternatives & Exception Paths

Answer Box If Blue Cross Blue Shield Virginia denies Cerezyme (imiglucerase) for Gaucher disease, you have three main paths: request a formulary exception with medical necessity documentation, consider FDA-approved alternatives like VPRIV or Elelyso if covered, or pursue Virginia's external review process through the State Corporation Commission. Start
6 min read